<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="129409">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01868776</url>
  </required_header>
  <id_info>
    <org_study_id>buffered anesthetic toothache</org_study_id>
    <nct_id>NCT01868776</nct_id>
  </id_info>
  <brief_title>Effect of Buffered Numbing Solution on Patients With Toothaches</brief_title>
  <official_title>Effect of Buffered Lidocaine on the Success of the Inferior Alveolar Nerve Block in Patients With Symptomatic Irreversible Pulpitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effect of buffered lidocaine (a numbing
      solution) on the ability to numb patients with toothaches. Buffered anesthetic (numbing)
      solutions have shown promise in some medical and dental research.  Patients presenting with
      toothaches will be given either a buffered numbing solution or a nonbuffered numbing
      solution.  Neither the patient nor the operator will know which solution they will receive.
      Root canal treatment will be performed on the tooth and the ability of the buffered versus
      non-buffered numbing solutions will be compared.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>pain measurement as assessed on a visual analog scale</measure>
    <time_frame>pain at time of treatment (after buffered versus nonbuffered numbing solution)</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Irreversible Pulpitis (Toothache)</condition>
  <arm_group>
    <arm_group_label>buffered lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4% lidocaine with 1:100,000 epinephrine/0.18 mEq/mL sodium bicarbonate.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>nonbuffered lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>4% lidocaine with 1:100,000 epinephrine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>buffered lidocaine</intervention_name>
    <arm_group_label>buffered lidocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>nonbuffered lidocaine</intervention_name>
    <arm_group_label>nonbuffered lidocaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with a diagnosis of irreversible pulpitis (toothache) in a    mandibular
             posterior tooth (back/bottom tooth) with moderate to severe pain

          -  ages 18 -65 years of age

          -  in good health (ASA I or II)

          -  able to grant informed consent.

        Exclusion Criteria:

          -  allergy to lidocaine (numbing solution

          -  significant medical problem (ASA III or IV)

          -  have taken CNS depressants or analgesic medications within the last 24 hours

          -  pregnancy or lactating

          -  non-English speaking

          -  inability to give informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The Ohio State University College of Dentistry, Postle Hall</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>DiFazio CA, Carron H, Grosslight KR, Moscicki JC, Bolding WR, Johns RA. Comparison of pH-adjusted lidocaine solutions for epidural anesthesia. Anesth Analg. 1986 Jul;65(7):760-4.</citation>
    <PMID>3717616</PMID>
  </reference>
  <reference>
    <citation>Zahl K, Jordan A, McGroarty J, Sorensen B, Gotta AW. Peribulbar anesthesia. Effect of bicarbonate on mixtures of lidocaine, bupivacaine, and hyaluronidase with or without epinephrine. Ophthalmology. 1991 Feb;98(2):239-42.</citation>
    <PMID>2008283</PMID>
  </reference>
  <reference>
    <citation>Sinnott CJ, Garfield JM, Thalhammer JG, Strichartz GR. Addition of sodium bicarbonate to lidocaine decreases the duration of peripheral nerve block in the rat. Anesthesiology. 2000 Oct;93(4):1045-52.</citation>
    <PMID>11020760</PMID>
  </reference>
  <reference>
    <citation>Richtsmeier AJ, Hatcher JW. Buffered lidocaine for skin infiltration prior to hemodialysis. J Pain Symptom Manage. 1995 Apr;10(3):198-203.</citation>
    <PMID>7629414</PMID>
  </reference>
  <reference>
    <citation>Burns CA, Ferris G, Feng C, Cooper JZ, Brown MD. Decreasing the pain of local anesthesia: a prospective, double-blind comparison of buffered, premixed 1% lidocaine with epinephrine versus 1% lidocaine freshly mixed with epinephrine. J Am Acad Dermatol. 2006 Jan;54(1):128-31.</citation>
    <PMID>16384767</PMID>
  </reference>
  <reference>
    <citation>Ackerman WE 3rd, Ware TR, Juneja M. The air-liquid interface and the pH and PCO2 of alkalinized local anaesthetic solutions. Can J Anaesth. 1992 Apr;39(4):387-9.</citation>
    <PMID>1314142</PMID>
  </reference>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 30, 2013</lastchanged_date>
  <firstreceived_date>May 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Melissa Drum</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pulpitis</mesh_term>
    <mesh_term>Toothache</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
